October 10, 2024
The Minnesota Department of Commerce annually solicits input from healthcare professionals, patient advocates, health insurers and the public to evaluate and report the potential impacts of legislative proposals. These evaluations provided to the Minnesota Legislature are known as 62J reports.
For the 2024-2025 cycle, the department will evaluate nine proposed health benefit mandates for potential fiscal, economic, and public health impacts.
A high-level summary of the proposed mandates and more information on how to submit comments is available here. To ensure the department has sufficient time to review suggested data sources and incorporate new information into the final evaluation reports, interested parties should submit comments by November 18, 2024.
Contact Ashley Setala at ashley.setala@state.mn.us with questions. The Minnesota Department of Commerce may follow up with RFI respondents to request additional information about their submissions as needed.
Here is the electronic form to submit comments.
April 9, 2026
An amended piece of legislation that would exempt buprenorphine from prior authorization (PA) was heard in the Senate Health and Human Services Committee on April 9.
April 9, 2026
On April 9, the Senate Health and Human Services Committee heard a bill that would require coverage for psychiatric Collaborative Care Model (CoCM) services under Medical Assistance.
April 9, 2026
On April 9, the House Taxes Committee heard legislation focused on supporting the financial stability and ongoing operations of Hennepin Healthcare.